Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Applovin
APP
|
+$751M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$692M |
| 3 |
Palantir
PLTR
|
+$434M |
| 4 |
Union Pacific
UNP
|
+$377M |
| 5 |
AbbVie
ABBV
|
+$367M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.74B |
| 2 |
Meta Platforms (Facebook)
META
|
+$602M |
| 3 |
Bank of America
BAC
|
+$600M |
| 4 |
Wells Fargo
WFC
|
+$568M |
| 5 |
Broadcom
AVGO
|
+$538M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.73% |
| 2 | Financials | 7.42% |
| 3 | Healthcare | 6.65% |
| 4 | Industrials | 6.3% |
| 5 | Consumer Discretionary | 5.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FBRT
5351
Franklin BSP Realty Trust
FBRT
$701M
| $137K | ﹤0.01% |
+12,858
| New | +$144K |
|
5352
Karyopharm Therapeutics
KPTI
$42.2M
| $137K | ﹤0.01% |
31,847
-23,520
| -42% | -$115K |
|
5353
Playboy Inc
PLBY
$150M
| $137K | ﹤0.01% |
84,554
-146,133
| -63% | -$188K |
|
5354
Fennec Pharmaceuticals
FENC
$400M
| $136K | ﹤0.01% |
+16,334
| New | +$112K |
|
5355
Destination XL Group
DXLG
$35.2M
| $134K | ﹤0.01% |
120,807
+89,106
| +281% | +$97.5K |
|
|
RUMBW
5356
CALL
RUM Group Inc Warrant
RUMBW
$16.7M
| $133K | ﹤0.01% |
43,045
| – | – |
|
5357
Invesco Trust Investment Grade Municipals
VGM
$556M
| $133K | ﹤0.01% |
+14,000
| New | +$134K |
|
|
MRDN
5358
Meridian Holdings Inc
MRDN
$179M
| $133K | ﹤0.01% |
+6,509
| New | +$142K |
|
5359
Envela
ELA
$367M
| $131K | ﹤0.01% |
21,412
-58,057
| -73% | -$360K |
|
5360
Noodles & Co
NDLS
$93.6M
| $131K | ﹤0.01% |
22,912
-3,725
| -14% | -$26K |
|
|
SOL
5361
DELISTED
Emeren Group
SOL
| $129K | ﹤0.01% |
+68,808
| New | +$107K |
|
5362
Ocean Power Technologies
OPTT
$49M
| $128K | ﹤0.01% |
+268,883
| New | +$128K |
|
5363
VinFast Auto
VFS
$7.23B
| $127K | ﹤0.01% |
35,520
+5,923
| +20% | +$20.1K |
|
|
TRVG
5364
trivago
TRVG
$394M
| $126K | ﹤0.01% |
33,402
+17,237
| +107% | +$71K |
|
5365
Gran Tierra Energy
GTE
$352M
| $125K | ﹤0.01% |
26,252
+12,781
| +95% | +$60.6K |
|
5366
PUT
Capricor Therapeutics
CAPR
$395M
| $124K | ﹤0.01% |
+12,500
| New | +$132K |
|
5367
DocGo
DCGO
$37.8M
| $123K | ﹤0.01% |
78,299
-3,835
| -5% | -$7.15K |
|
|
IRD
5368
Opus Genetics
IRD
$335M
| $120K | ﹤0.01% |
+127,844
| New | +$118K |
|
|
AACBR
5369
DELISTED
Artius II Acquisition Inc Rights
AACBR
| $120K | ﹤0.01% |
+500,000
| New | +$112K |
|
|
NB
5370
NioCorp Developments
NB
$619M
| $120K | ﹤0.01% |
+51,498
| New | +$128K |
|
5371
LSB Industries
LXU
$772M
| $120K | ﹤0.01% |
15,336
-14,405
| -48% | -$98.7K |
|
|
BRSP
5372
BrightSpire Capital
BRSP
$621M
| $119K | ﹤0.01% |
23,607
-223,539
| -90% | -$1.13M |
|
|
AKYA
5373
DELISTED
Akoya BioSciences
AKYA
| $119K | ﹤0.01% |
91,576
-21,669
| -19% | -$26.1K |
|
5374
Inseego
INSG
$72.1M
| $119K | ﹤0.01% |
14,447
-162,357
| -92% | -$1.27M |
|
|
UHGWW
5375
CALL
DELISTED
United Homes Group Warrant
UHGWW
| $119K | ﹤0.01% |
146,359
-1,155
| -0.8% | -$608 |
|
Similar funds
Israel Englander's Q2 2025 Portfolio in Review
As of Q2 2025, Israel Englander held 6,516 positions worth $207B, up 10% from $188B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Israel Englander's Q2 2025 filing shows 738 new, 2,295 increased, 2,418 reduced and 712 closed positions. Its largest new stake was Bank of America Series L: 164,000 shares worth $197K. The largest sale was iShares Core S&P 500 ETF, an estimated $1.74B.
By sector, the portfolio is most concentrated in Technology at 8.7% of assets, up from 7.8% a quarter earlier, followed by Financials and Healthcare.
- Israel Englander's largest Q2 2025 buy was Bank of America Series L: 164,000 shares worth $197K.
- Israel Englander added most to Applovin in Q2 2025, an estimated $751M increase.
- Israel Englander's biggest Q2 2025 reduction was iShares Core S&P 500 ETF, cutting an estimated $1.74B.
- Israel Englander fully exited Discover Financial Services in Q2 2025, selling an estimated $282M.
- Israel Englander's ten largest holdings make up 16% of its $207B portfolio in Q2 2025.
- Israel Englander opened 738 new positions and closed 712 in Q2 2025.
- Israel Englander's portfolio value rose 10% quarter-over-quarter to $207B.
Based on Millennium Management's 13F filing for Q2 2025, filed 14 Aug 2025.